289 related articles for article (PubMed ID: 25675486)
1. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
[TBL] [Abstract][Full Text] [Related]
2. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
[TBL] [Abstract][Full Text] [Related]
3. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.
Hervé M; Ibrahim EC
Neurobiol Dis; 2017 Jul; 103():113-122. PubMed ID: 28404519
[TBL] [Abstract][Full Text] [Related]
5. Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm(5)s(2)U in tRNA.
Karlsborn T; Tükenmez H; Chen C; Byström AS
Biochem Biophys Res Commun; 2014 Nov; 454(3):441-5. PubMed ID: 25450681
[TBL] [Abstract][Full Text] [Related]
6. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Jun; 306(1):303-9. PubMed ID: 12788105
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
[TBL] [Abstract][Full Text] [Related]
8. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.
Ajiro M; Awaya T; Kim YJ; Iida K; Denawa M; Tanaka N; Kurosawa R; Matsushima S; Shibata S; Sakamoto T; Studer L; Krainer AR; Hagiwara M
Nat Commun; 2021 Jul; 12(1):4507. PubMed ID: 34301951
[TBL] [Abstract][Full Text] [Related]
10. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
[TBL] [Abstract][Full Text] [Related]
11. Familial dysautonomia.
Slaugenhaupt SA; Gusella JF
Curr Opin Genet Dev; 2002 Jun; 12(3):307-11. PubMed ID: 12076674
[TBL] [Abstract][Full Text] [Related]
12. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
[TBL] [Abstract][Full Text] [Related]
13. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.
Keren H; Donyo M; Zeevi D; Maayan C; Pupko T; Ast G
PLoS One; 2010 Dec; 5(12):e15884. PubMed ID: 21209961
[TBL] [Abstract][Full Text] [Related]
15. Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.
Anderson SL; Liu B; Qiu J; Sturm AJ; Schwartz JA; Peters AJ; Sullivan KA; Rubin BY
Mol Nutr Food Res; 2012 Apr; 56(4):570-9. PubMed ID: 22495984
[TBL] [Abstract][Full Text] [Related]
16. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
[TBL] [Abstract][Full Text] [Related]
17. Rectifying RNA splicing errors in hereditary neurodegenerative disease.
Swanson MS
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2637-8. PubMed ID: 25691745
[No Abstract] [Full Text] [Related]
18. [Molecular and cellular characterization ion of IKAP protein and the Elongator complex. Implications for familial dysautonomia].
Close P; Creppe C; Cornez I; Chariot A
Bull Mem Acad R Med Belg; 2007; 162(5-6):315-22. PubMed ID: 18405001
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice.
Sinha R; Kim YJ; Nomakuchi T; Sahashi K; Hua Y; Rigo F; Bennett CF; Krainer AR
Nucleic Acids Res; 2018 Jun; 46(10):4833-4844. PubMed ID: 29672717
[TBL] [Abstract][Full Text] [Related]
20. Retina-specific loss of
Ueki Y; Shchepetkina V; Lefcort F
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29929962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
